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ABSTRACT
Objective: This study aimed to optimize and evaluate the controlled release rate, ocular irritancy, and in vitro antimicrobial properties of levofloxacin 
entrapped in the epichlorohydrin-crosslinked hydrogel of sodium carboxymethyl cellulose (NaCMC) and gelatin.
Materials and Methods: Various parameters such as polymer ratio, amount of crosslinker, temperature, reaction time, swelling capacity, and percent 
drug loading were considered in Optimized levofloxacin hydrogel. Hydrogel preparations with higher amount of drug loaded were further analyzed 
to determine its in vitro drug release rate, ocular irritancy on New Zealand rabbits, and antimicrobial activities against Pseudomonas aeruginosa 
and Staphylococcus aureus. Optimized levofloxacin hydrogel (OLH) was then subjected to 3-month stability testing at 40 ± 2°C and 75 ± 5% relative 
humidity in which samples were withdrawn at the end of each month for analysis.
Results: Polymer groups with higher concentrations of NaCMC have higher swelling and drug loading capacities than those with higher gelatin 
concentrations. Meanwhile, qualitative analysis using differential scanning calorimetry, Fourier-transform infrared spectroscopy, and scanning 
electron microscopy verified the presence of levofloxacin in the epichlorohydrin-cross-linked hydrogel. Among the four polymer ratio, F3 was the 
optimized hydrogel with drug-loaded concentration of 99.50%, which was within the acceptable assay limit of 0.5% levofloxacin solution based on 
United States Pharmacopeia monograph. It followed the Higuchi kinetic model with a drug release mechanism of super case 2 transport indicating 
hydrogel swelling as a key factor for its controlled drug release. In vitro, antibacterial test against P. aeruginosa and S. aureus was sensitive to optimized 
levofloxacin hydrogel (OLH) with inhibitory diameter zones of 31.68 and 37.05 mm, respectively. Ocular irritancy test also showed that the OLH is 
non-irritating on installation in the cul-de-sac of New Zealand rabbits.
Conclusion: Optimized levofloxacin hydrogel was effective, non-irritating, and stable, which can be used as an alternative to conventional 0.5% 
levofloxacin ophthalmic solution.
Keywords: Cross-linked hydrogel, Levofloxacin, Ophthalmic preparation.
INTRODUCTION
Misuse and overuse of antimicrobials impair their abilities to treat 
infections. It can also prolong illnesses which may lead to disabilities 
and deaths. Eye infections such as bacterial and fungal keratitis are 
one of the major causes of ophthalmic morbidities and visual loss 
with a reported incidence of 17–36% worldwide [1]. It is also a second 
predisposing factor of corneal opacifications which is commonly 
associated with soft contact lens users with a reported annual ulcerative 
keratitis incidence of 4–21/10,000 daily and extended wear users [2]. 
In this case, clinicians use varieties of antibacterial eye preparations 
and reports have shown that ocular pathogens show minimal bacterial 
resistance with fluoroquinolones [3] such as 0.3% ciprofloxacin and 
0.5% levofloxacin which are efficient against aminoglycoside-resistant 
Pseudomonas aeruginosa and methicillin-resistant Staphylococcus 
aureus.
Levofloxacin, a fourth-generation fluoroquinolone and an active 
L-isomer of Ofloxacin, is proven safe in treating bacterial conjunctivitis, 
keratitis, and other eye infections with known mechanism of inhibiting 
DNA gyrase and topoisomerase IV which are important steps for 
bacterial DNA metabolism [4]. It is registered as Quixin® (US), 
Oftaquix® (Europe), and Cravit® (Japan) with disadvantages similar to 
conventional eye preparations, such as rapid tear turnover and drug 
impermeability to corneal epithelium membranes similar to other 
conventional eye drops. Patient non-compliance is also an issue due to 
high frequencies of eye drop installations, which is a contributory factor 
to microbial resistance aside from improper dosage regimen, misuse, 
and overuse of topical antibacterial and extended duration of therapy.
In situ, hydrogel is a polymer liquid solution that undergoes a phase 
transition to semisolid gel due to changes in pH, temperature, and ion 
activation. On addition of a crosslinker specifically epichlorohydrin, 
its mechanical strength, and swelling properties will be enhanced, 
allowing diffusion of water-soluble drug into the hydrogel [5].
The main thrust of this study was to enhance the permeability and release 
rate of levofloxacin through drug entrapment in an epichlorohydrin-




Epichlorohydrin and the reference standard levofloxacin were purchased 
from Sigma-Aldrich, while the high-performance liquid chromatography 
grade methanol for OLH analysis was purchased from Merck. Other 
analytical grade chemicals were acquired from Aishite Trading.
Methods
Compatibility testing
Thermograms of individual and combined ingredients were obtained 
using PerkinElmer differential scanning calorimetry (DSC) 400 in which 
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5 mg samples of Na CMC, gelatin and levofloxacin were pre-heated in 
sealed aluminum pans from 30 to 300°C at 10°C/min.
Hydrogel formulation
Various proportions of Na CMC and gelatin, as shown in Table 1, 
were dissolved with 50 mL distilled water. Dropwise of 10 µL of 
epichlorohydrin was added using a micropipette. The mixture was 
continuously stirred before it was spread evenly on glass plates. The 
semisolid mixture was heated inside the oven at 45°C for 240 min 
to facilitate the chemical reaction between the polymer and added 
crosslinker. Film thickness and weight of dried hydrogels were 
determined using a Vernier caliper and Kern Analytical Balance.
Drug loading
One milliliter of loaded hydrogel was then diluted with 100 mL simulated 
tear fluid (STF) pH 7.4. Five-milliliter aliquot samples were withdrawn, 
further diluted to 25 mL STF and then analyzed using ultraviolet-visible 
(UV-VIS) spectrophotometer (Unico SQ3802E) at 294 nm. Drug loading 
in the hydrogel was determined using the formula: Drug loading 
percentage = t1−t2, where t1 was the initial drug concentration in the 
solution and t2 is the concentration in the supernatant solution.
Hydrogel characterization
A. Fourier-transform infrared (FTIR) spectroscopy – Functional groups 
present on dried OLH were analyzed using PerkinElmer Spectrum 
Two at 550-4000 cm-1 range at 4/cm resolution
B.	 Scanning	electron	microscopy	(SEM):–	Sufficient	samples	fixed	with	
electroconducting glue were coated with gold powder, and its surface 
morphologies were analyzed using JSM-5310 (×1500, ×3500, ×7500, 
and	×10000	magnifications)	with	a	maintained	voltage	of	10	kV
C. Swelling kinetics and maximum swelling degree – Pre-weighed and 
dried OLH samples were immersed in distilled water for 72 h at 25°C. 
Swollen	hydrogels	were	dried	with	filter	paper	and	weighed.	Using	
the Dogadkin method, the percentage swelling of the hydrogel was 
calculated using the formula: Q1=((ms– mo))/ms)(100)), where Q1 was 
the swelling degree at time t, ms was the weight of swollen hydrogel 
at time t, and md was the weight of the dry hydrogel. The maximum 
water absorbed by OLH was also calculated using the formula for 
equilibrium water content (EWC): EWC (%) = ((ms– mo)/ms)(100), 
where ms was the weight of swollen hydrogel at equilibrium [6].
In vitro drug release
A freshly prepared STF was prepared using the procedure given by 
Rajesh et al. (2012). The semi-permeable cellophane membrane was 
soaked for 24 h in STF. It was then wrapped in the stainless basket of 
the dissolution tester. One milliliter of OLH was transferred into the 
basket and suspended in a fiberglass vessel which acted as an acceptor 
chamber containing 500 mL STF. The temperature of the acceptor 
chamber was maintained at 37 ± 2°C with a constant stirring rate of 
50 rpm. Four-milliliter sample was withdrawn every hour for up to 
8 h and replaced with an equal volume of fresh diffusion medium [7]. 
Diluted aliquots in the diffusion medium were then analyzed at 294 nm 
wavelength using UV-Spectrophotometer. The same procedure was 
done using 1 mL marketed 0.5% levofloxacin solution (Oftaquix®). Data 
gathered were used to analyze the in vitro release rate of OLH using 
different kinetic models [8].
a.	 Zero-order	kinetics	–	where	percentage	levofloxacin	released	in	mg	
(Q) was plotted against time
b. First-order kinetics – where Q was plotted against time
c. Higuchi model – where Q was plotted against the square root of time
d. Hixson-Crowell model – where Mo1/3	−	Mt1/3 was plotted against 
time
e. Korsmeyer–Peppas model – where log Q was plotted against log time.
Antimicrobial activity
Using agar well method, an aliquot of 0.5 mL inoculums of test 
microorganisms (S. aureus ATC 25923 and Pseudomonas aeruginosa 
ATC 27853) were spread onto the agar plates and dried inside the 
biosafety cabinet. It was then punched aseptically with a sterile cork 
borer and filled with 100 µL of hydrogel (negative control), 100 µL of 
0.5% levofloxacin solution (positive control), and 100 µL of OLH. The 
plates were incubated at 37°C and zones of inhibition were measured 
after 24 h using a Vernier caliper.
Ocular irritancy test
One to two drops of 0.5% proparacaine, HCl was administered on each 
eye 5 min before instilling 0.1 mL of OLH into the left cul-de-sac of three 
male New Zealand rabbit. The rabbits were monitored for 3 days for 
corneal opacity, reaction to light, eye redness, and swelling.
Accelerated stability studies
Three batches of the OLH were filled in glass vials securely closed 
to avoid moisture absorption. It was kept inside a stability oven 
with a maintained temperature of 40 ± 2°C and 75 ± 5% relative 
humidity for 3 months. Samples were withdrawn monthly to check 
the following: Organoleptic appearance, pH, viscosity, spreadability, 
gelling capacity, drug content, antimicrobial activity, and additional 
qualitative analysis using DSC, FTIR, and SEM to determine any 




Thermograms of each excipient were determined through the use 
of DSC (PerkinElmer DSC 400) in which initial peaks between 90° 
and 115°C was observed on most samples indicating desolvation. 
Meanwhile, levofloxacin was identified on DSC thermogram by its 
sharp endothermic peak at 238.68°C, gelatin at 262.55°C, and Na 
CMC at 90.76°C. When mixing levofloxacin with Na CMC, two sharp 
endothermic peaks at 228.65 and 236°C were observed indicating 
complex formation. However, a different endothermic peak at 214.80°C 
was observed when it is mixed with gelatin, and it even lowered 
on physical mixing of levofloxacin with gelatin and NaCMC with an 
evident broad peak at 211.50°C. According to Mutyaba et al. (2012), 
the mixing of drug and excipients may cause minor changes in the 
melting endotherm of a drug such as peak broadening or shifting 
toward the lower temperature. This is due to the lowering of the purity 
concentration of each component that does not necessarily indicate 
potential incompatibility.
A higher glass transition temperature at 220.34°C was observed with 
the crosslinked and loaded hydrogel at 0 month. This is due to the 
presence of covalent bond on addition of epichlorohydrin which leads 
to the formation of a mechanically stable hydrogel [9] in which its 
amorphous region requires a higher heat capacity [10] in the reversible 
transition of hard, brittle polymer into its molten rubber-like state [11].
Table 1: Formulation parameters in preparing optimized levofloxacin hydrogel (OLH)
Formulation code Polymer concentration Temperature (°C) Reaction time (min)
F1 20% CMC+80% gelatin 45 240
F2 40% CMC+60% gelatin
F3 60% CMC+40% gelatin
F4 80% CMC+20% gelatin
CMC: Carboxymethyl cellulose
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Variables influencing the entrapment process
Different parameters, such as the polymer ratio, amount of crosslinker, 
temperature, reaction time, and swelling capacity, were considered in 
optimizing levofloxacin hydrogel. Based on the results shown in Table 2, 
hydrogels with greater amount of polysaccharides are heavier in weight, 
thinner, and have greater swelling capacity and thus, can be classified 
as super absorbent gel. This is due to a chemical reaction between the 
polymer mixture and anionic ion (F−) present in epichlorohydrin which 
results to the formation of a permanent network which increases the 
mechanical strength and swelling capacity of the hydrogel. In addition, 
the carboxyl group present in NaCMC increased the electrostatic 
repulsions between the polymeric chains which permit fluid entry into 
the hydrogel, causing it to swell greatly [9].
Syneresis or the phenomenon of hydrogel shrinkage due to matrix 
coarsening or continuous squeezing-out effect, was observed on F1 due 
to decreased amount of NaCMC. This result is contrary to the findings 
of Buhus et al. (2009) in which hydrogel swelling degree in water is 
dependent on gelatin concentration [12].
Drug loading
The United States Pharmacopeia acceptance limit for the assay of 0.5% 
levofloxacin solution is 90–110% of its labeled claim in which the drug 
concentrations of the four groups were within the limit: F1 (99.03%), 
F2 (99.11%), F3 (99.50%), and F4 (99.51%). Cross-linked hydrogels 
with higher amount of Na CMC have greater amounts of levofloxacin 
loaded into it, such as in the case of F3 and F4. As mentioned earlier, 
this is due to the carboxyl group present in Na CMC, but this result is 
different from the findings of Buhus et al. (2009) wherein the quantity 
of CMC decreases drug loading into the hydrogel because of the 
repulsive interaction between CMC and chloramphenicol in which both 
are anionic in nature. Using one-way ANOVA, the acquired p = 0.427 
which indicates that there is no significant difference between the 
means of the four groups indicating that drug loading is independent 
on polymer ratio of NaCMC and gelatin.
Hydrogel surface characteristics
Qualitative analysis was used to analyze the surface of the hydrogel 
wherein the functional groups such as O-H, C=O, and C-O were identified 
using FTIR indicating the formation of interconnected networks and 
efficient entrapment of levofloxacin inside cross-linked hydrogel at 
1586.97/cm (Fig. 1).
As seen on SEM, the surface of uncrosslinked hydrogel was rough with 
irregularly-shaped pores, as shown in Fig. 2a-c. Unlike with cross-
linked hydrogel on Fig. 2d-f, its intermolecular network chains were 
evident with 146 pores and an average pore area ratio of 61.27% due 
to added epichlorohydrin which stabilizes the structure and making it 
macroporous which is a good indication of a superabsorbent gel [13].
According to Ahmad et al. (2016), porosity is significant for drug loading 
due to its affinity with the aqueous medium causing the hydrogel to swell 
and this is evident on Fig. 2g-i in which the pores of loaded hydrogel have 
closed as it swelled due to diffusion of levofloxacin solution into the cross-
linked hydrogel with 31 pores and average pore area ratio of 10.29%.
In vitro diffusional models and kinetics
F3 and F4 hydrogels were selected due to its swelling property and drug 
loading percentage. As shown in Fig. 3, Oftaquix® was immediately released 
Fig. 1: Fourier-transform infrared spectra of crosslinked (60C:40G) and loaded hydrogels (H60C:40G)















F1 0.11 0.77 −23.62 −319.12
F2 0.28 0.70 1111.45 341.27
F3 0.44 0.48 1410.66 177.59
F4 0.66 0.35 1626.82 348.01
EWC: Equilibrium water content
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in simulated tear with higher drug concentration during the first 2 h but 
became constant on the 6th h. Meanwhile, loaded hydrogels were slowly 
released due to its viscosity, which took an hour before its concentration 
in the dissolution medium has increased. This can be explained by 
the findings of Hoosain et al. (2014) in which controlled swelling and 
dissolution are the two known mechanisms of how the drug is released 
from the hydrophilic matrix system. When a porous hydrogel is placed 
in an aqueous dissolution medium, the available pores allow diffusion of 
the drug within the surface of the matrix. It further allows water entry 
and closes when filled with the dissolution medium. The gellification of 
the system due to swelling leads to the dissolution of the polymer causing 
drug to be released. In addition, swelling rate and drug release at the time 
(t) are inversely proportional to each other. It means increased in swelling 
reduces the drug release rate because the drug molecule has to traverse 
the gel layer before it is released into the dissolution medium.
Table 3 suggests Higuchi as the kinetic model for loaded hydrogels 
with R = 0.991 (F3) and 0.994 (F4). As explained by Hoosain et al. 
(2016), drug diffusion from the polymeric network in Higuchi kinetics 
is decreasing when the distance for diffusion is increasing. It means 
the increase in distance will reduce the concentration of diffused 
levofloxacin in the STF. To explain the effect of swelling on matrix 
on hydration, Korsmeyer–Peppas exponent values were used [9] in 
which both hydrogels were described as fine films under super Case II 
transport wherein the classified release mechanism of F4 is anomalous 
transport (n = 0.951), while the drug release rate of F3 (n = 1.311) is 
controlled by hydrogel swelling in the dissolution medium and is time-
independent with zero-order kinetics.
The mean differences of drug released per time were analyzed using 
two-way ANOVA in which the acquired p = 4.6044 × 10-8 indicating 
a significant difference; nevertheless, the drug release rate of each 
treatment group is still not significant from each other (p = 0.623).
In vitro bactericidal activities
Unloaded hydrogels did not exhibit any antibacterial activities against 
P. aeruginosa and S. aureus. However, if treated with loaded hydrogels, 
these common ocular pathogens were sensitive in which F3 has greater 
inhibitory zone of 31.68 and 37.05 mm, respectively. Using one-way 
ANOVA to the mean difference of Oftaquix® and F3 against P. aeruginosa, 
it was found that there is no significant difference (p = 0.897) on their 
antimicrobial property except for F4 with acquired p = 0.034. The result 
for S. aureus is also the same with no significant difference with F3 
(p = 0.991) and F4 (p = 0.859).
Ocular irritancy profile
F3 was considered the optimized hydrogel among the four groups and 
instilled into the cul-de-sac of New Zealand rabbits. No visible signs of 
ocular damage had been observed within the 3-day treatment. Hence, 
the optimized levofloxacin hydrogel is non-irritating and safe as a 
treatment for ocular infections.
Stability profile of optimized levofloxacin hydrogel
Three batches of 50 g optimized levofloxacin hydrogel (OLH) were 
prepared for accelerated stability studies for 3 months at 40 ± 2°C and 
75 ± 5% relative humidity. As shown in Table 4, the OLH was pale yellow 
in color at 0 month. It is homogenous and nongritty in texture with an 
average pH of 3.94 and spreadability value of 0.430. Its viscosity made 
the hydrogel not flowable, but it gelled immediately with STF that last 
for more than 1 h.
After its 1st month inside the stability oven, the OLH still remained 


























Fig. 3: Comparison of the in vitro drug release profile of 
levofloxacin from F3, F4, and 0.5% levofloxacin eye drops 
(Oftaquix®)
Table 3: Kinetic model of OLH and Oftaquix®
Formulation code R Korsmeyer‑Peppa
Zero-order First-order Higuchi Hixson‑Crowell R n
F4 0.9534 0.7248 0.9938 0.8358 0.9692 0.9514
F3 0.9307 0.7406 0.9905 0.8236 0.9754 1.311
Oftaquix 0.7993 0.7072 0.9168 0.7409 0.9620 3.2485
Table 4: Stability profile of OLH
Parameters 0 month 1st month 2nd month 3rd month












pH 3.94±0.01 4.07±0.01 4.13±0.01 4.18±0.01
Viscosity (cp) 11.867±0.03 10.643±0.04 9.958±0.02 9.043±0.09
Spreadability ( g × cm
s
) 0.430±0.08 0.601±0.07 0.376±0.06 0.399±0.10
Gelling capacity +++ ++ + +
+: The vehicle is in liquid form which gels slowly and remains in less than an hour, ++: The vehicle is a liquid-gel, flows readily, and shows immediate gelation that 
remains for an hour, +++: The vehicle is a highly viscous gel, flows less readily and shows immediate gelation that remains for more than an hour
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condition, its color turned into light yellow, pH increased to 4.07, 
while its viscosity decreased to 10.643 cp, making it liquid-gel 
in appearance that flowed less readily. Changes have still been 
observed for the next 2 months in which OLH at 3rd month was 
now yellow-orange in color, pH 4.18, and less viscous compared to 
0 month in which the gel rapidly dissolved in STF. Loss of viscosity 
on storage is a common limitation of natural polymer especially 
when exposed at extreme temperature, but this can be improved 
by chemical modifications such as crosslinking, blending, and 
formation of interpenetrating polymer networks [10]. Changes in the 
pH and color of OLH are possibly an initial indication of levofloxacin 
degradation because quinolones are light sensitive and undergo 
photodegradation by first-order kinetics but this can be hindered 
by increasing the solvent viscosity, using of organic solvents, or 
formulating liquid preparations within pH 5–7 because degradation 
is greater in aqueous medium and higher pH due to formed cationic, 
dipolar, and anionic species caused by pH changes [14]. As observed, 
the viscosity of OLH is still acceptable for sustained-release 
ophthalmic preparations, and it decreases further degradation of 
levofloxacin at extreme storage conditions.
In addition, a significant increase in drug concentration of the OLH every 
month was observed [Table 5] in which the absorbance of hydrogel 
at 3rd month was higher than at 0 month as an effect of increased 
temperature, changes in pH, and presence of unreacted epichlorohydrin 
which aid in the continued swelling and drug loading of the polymer. 
According to Budianto et al. (2015), these ionic interactions are due to 
dissociation of hydrogen bonds in gelatin with water molecules present 
inside the hydrogel matrix.
At ×3500 magnification, as shown in Fig. 4a, the in-between spaces 
of OLH at 3rd month were now shallow compared to its SEM image at 
0 month in which most of the pores are deep and irregularly-shaped. 
The tightening of the pores was due to continued entrapment of 
unloaded levofloxacin into the hydrogel. Crystals were also observed 
on its surfaces.
Fig. 5 indicates that the OLH at 3rd month was very well hydrated 
as shown by its endothermic peak at 79.53°C. It is because 
hydrogel films made from cellulose are vulnerable to moisture 
absorption [15] especially polymers containing high CMC content 
due to its high water vapor affinity which allows diffusion of water 
vapor molecules into the film causing it to swell greatly [16]. In 
addition, two sharp peaks at 223.20 and 243.57°C were observed, 
and this is due to crystallization, which was similarly observed on 
SEM image at ×3500 magnification. Increase in film crystallinity 
and high water vapor permeability decreases the amorphous 
properties of hydrogel film [17] leading to higher glass transition 
as evident by a shift to a higher temperature. It is an indication of 
strong hydrogen bonds due to continued crosslinking [10] caused 
by changes in temperature and pH.
There was no evident changes in the FT-IR spectra of OLH at 0 and 
3rd month [Fig. 6]. It was still the same indicating the presence of 
O-H broad peaks at 3371.80/cm and 3388.87/cm, C=O stretch at 
1575.65/cm, and C-O bond at 1009.44/cm and 1030.69/cm.
Antimicrobial activity
The three batches of the OLH have retained their antibacterial activities 
against P. aeruginosa and S. aureus with mean zones of inhibition 
of 32.64 mm [Table 6] and 40.22 mm [Table 7], respectively.. These 
indicate the sensitivity of these common ocular pathogens to the 
optimized hydrogel. However, Oftquix® had greater inhibitory zone 
for these two ocular pathogens with an average diameter of 37.24 and 
40.63 mm, respectively.
Fig. 5: Differential scanning calorimetry thermogram of OLH at 3rd month
Table 5: High performance liquid chromatography analysis of OLH
Stability period 
(40±2°C, 75±5% RH)
0 month 1st month Percentage 
difference
2nd month Percentage 
difference
3rd month Percentage 
difference
Batch 1
 (concentration in mg)
4.959±0.014 4.971±0.010 0.24 4.975±0.002 0.08 4.975±0.007 0
Batch 2 
(concentration in mg)
4.964±0.005 4.972±0.006 0.16 4.973±0.007 0.02 4.973±0.001 0
Batch 3 
(concentration in mg)
4.967±0.009 4.968±0.004 0.02 4.972±0.005 0.08 4.978±0.004 0
Fig. 4: Scanning electron microscopy image of OLH at 3rd month
ba
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On the other hand, the mean difference between Oftaquix® and 
OLH against P. aeruginosa and S. aureus was statistically significant 
from each other (p = 0.000) using two-tailed paired sample t-test 
indicating that the antimicrobial activity of Oftaquix® is still superior 
to OLH.
Finally, data analysis using linear regression demonstrates that the 
optimized levofloxacin hydrogel follows zero-order kinetics with a half-
life of 689 months and a shelf-life of 138 months when stored at 40°C.
CONCLUSION
The optimized levofloxacin hydrogel was stable for 3 months at 40°C. 
Its permeability, release rate and in vitro antibacterial activity were 
enhanced by formulating it into cross-linked hydrogel. In addition, it was 
non-irritating and can be used as an alternative for conventional 0.5% 
levofloxacin ophthalmic solution. Further studies should investigate its 
long-term stability and may initiate cost-analytical studies to determine 
its feasibility for commercialization.
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